¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"glycogen storage disease type II"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • moyamoya disease
    ¸ð¾ß¸ð¾ßº´
  • muscle disease
    ±ÙÀ°º´
  • mycobacterial disease
    Ç×»ê±Õº´, ¹ÌÄÚ¹ÚÅ׸®¾Æº´
  • mycoplasma disease
    ¹ÌÄÚÇö󽺸¶º´
  • maple syrup urine disease
    ´Üdz½Ã·´´¢º´
  • marble bone disease
    ´ë¸®¼®º´, °ñÈ­¼®º´
  • Marburg disease
    ¸¶¸£ºÎ¸£Å©º´
  • Marburg virus disease
    ¸¶¸£ºÎ¸£Å©¹ÙÀÌ·¯½ºº´
  • Marchiafava-Bignami disease
    ¸¶¸£Å°¾ÆÆÄ¹Ù-ºñ³Ä¹Ìº´
  • mast cell disease
    ºñ¸¸¼¼Æ÷º´
  • McArdle¡¯s disease
    ¸Æ¾Æµéº´
  • medullary cystic disease
    ¼ÓÁú³¶º´, ¼öÁú³¶¼ºº´
  • Menetrier disease
    ¸Þ³×Æ®¸®¿¡º´
  • metabolic disease
    ´ë»çº´, ´ë»çÁúȯ
  • metazoan disease
    ÈÄ»ýµ¿¹°º´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • molecular disease
    ºÐÀÚº´
  • motor neuron disease
    ¿îµ¿½Å°æ¼¼Æ÷º´
  • mountain disease
    °í»êº´
  • moyamoya disease
    ¸ð¾ß¸ð¾ßº´
  • muscle disease
    ±ÙÀ°º´
  • mycobacterial disease
    Ç×»ê±Õº´
  • mycoplasma disease
    ¹ÌÄÚÇö󽺸¶º´
  • neoplastic disease
    Á¾¾çº´, ½Å»ý¹°º´
  • nervous disease
    ½Å°æº´
  • neurohypophysial disease
    ½Å°æ³úÇϼöüº´
  • neuromuscular disease
    ½Å°æ±ÙÀ°º´
  • neuropathic joint disease
    ½Å°æº´Áõ°üÀýº´
  • notifiable disease
    ½Å°í´ë»óÁúº´
  • nutritional disease
    ¿µ¾çº´
  • nutritional deficiency disease
    ¿µ¾ç°áÇ̺´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • Weils disease
    ¿ÍÀϺ´(Ȳ´ÞÃâÇ÷¼º ·¾Å佺ÇǶóÁõ).
  • Weils disease
    ¿ÍÀϺ´(Ȳ´ÞÃâÇ÷¼º ·¾Å佺ÇǶóÁõ).
  • Weils disease
    ¿ÍÀϺ´(Ȳ´ÞÃâÇ÷¼º ·¾Å佺ÇǶóÁõ).
  • Wernicke s disease
    º£¸£´ÏÄɺ´.
  • Wernickes disease
    º£¸£´ÏÄɺ´.
  • Wilsons disease
    Àª½¼º´
  • accumulation disease
    ÃàÀûº´(õëîÝÜ»).
  • acquired cystic disease of the kidney
    ÈÄõ¼º ½Å³¶Æ÷Áúȯ
  • acquired disease
    ÈÄõ¼º Áúº´(¡­òðÜ»).
  • acquired heart disease =AHD
    ÈÄõ¼º ½ÉÁúȯ(¡­ãýòðü´).
  • acute demyelinating disease
    ±Þ¼º Å»¼öÃʼº Áúȯ(¡­÷­âÐõ¦àõòðü´).
  • acute febrile neutrophilic dermatosis ; Sweet disease
    ±Þ¼º À¯¿­ È£Áß±¸¼º ÇǺÎÁõ.
  • acute febrile neutrophilic dermatosis = Sweet disease
    ±Þ¼º À¯¿­ È£Áß±¸¼º ÇǺÎÁõ
  • acute infectious disease
    ±Þ¼º °¨¿°Áúȯ
  • acute infectious disease =AID
    ±Þ¼º Àü¿°º´(¡­îîæøÜ»).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • acute respiratory disease =ARD
    ±Þ¼º È£Èí±âº´(¡­û¼ýåÐïÜ»).
  • addisons disease
    ¾Öµð½¼º´(¡­Ü»)
  • addisons disease
    ¾Öµð½¼º´<<ºÎ½Å±â´ÉºÎÀü>>
  • adipose tissue disease
    Áö¹æÁ¶Á÷Áúȯ.
  • adjuvant disease
    ¾ÖÁÖ¹øÆ®º´.
  • adrenal cortex disease
    ºÎ½ÅÇÇÁúÁúȯ(Üùãìù«òõòðü´).
  • adult disease
    ¼ºÀκ´(à÷ìÑÜ»).
  • african sleeping disease
    ¾ÆÇÁ¸®Ä« ¼ö¸éº´(¡­â²ØùÜ»)
  • air borne disease
    °ø±â¸Å°³Áúȯ.
  • air pilots disease
    ºñÇàÁ¶Á¾»çº´.
  • air space disease
    °ø±â °ø°£ Áúȯ
  • aircraft disease
    Ç×°øº´.
  • albers-sch berg disease
    ¾Ëº£¸£½º-½¨º£¸£Å© º´(¡­Ü»)
  • albers-schonberg disease
    ¾Ëº£¸£½º-½¨º£¸£Å©º´(¡­Ü»)
  • alcoholic liver disease
    ¾ËÄڿüº °£Áúȯ(¡­àõ ÊÜòðü´)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 18
MCD magnetic circular dichroism; mast-cell degranulation; mean cell diameter; mean of consecutive differ...
MDV Marek disease virus; mean dye [bolus] velocity; mucosal disease virus
MJD Machado-Joseph disease; Mseleni joint disease
MRD maximum rate of depolarization; measles-rindenpest-distemper [virus group]; medical records departme...
MVD Doctor of Veterinary Medicine; microvascular decompression; mitral valve disease; multivessel corona...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 18
CR1 Complement receptor type one
CRPS-I Complex Regional Pain Syndrome Type I
CDA II Congenital dyserythropoietic anaemia type II
CTMC Connective tissue-type mast cells
COX-2 Cyclo-oxygenase-type-2
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Niemann disease
    ´Ï¸¸ÇÈ Áúȯ
    »ýÈÄ ¸î °³¿ùÂë ÇØ¼­ ¹ßº´Çϴµ¥, ½ÉÇÑ °£ºñ Á¾Ã¢, ºÎÁ¾, º¹¼ö, ÇǺÎÀÇ È²»öÁ¶ µîÀÇ Áõ»óÀ» º¼ ¼ö ÀÖ°í, Á¶Á÷ÇÐÀûÀ¸·Î´Â ¸Á³»°è ¼¼Æ÷°¡ ´Ù·®ÀÇ ¸®Æ÷À̵带 ޽ÄÇÏ¿© ´Ï¸¸-ÇÇÅ© ¼¼Æ÷·Î º¯È­ÇØ °£´Ù.
  • Norrie's disease ¸Á¸· ±âÇü¿¡ ÀÇÇÑ ¾çÂÊ ´«ÀÇ ½Ç¸í, Á¤½Å ¹ß´Þ Áö¿¬, ³­Ã»ÀÌ ³ªÅ¸³ª´Â À¯Àü¼º ÁúȯÀ¸·Î¼­ ¹Ý¼º À¯ÀüÀ¸·Î Àü´ÞµÈ´Ù.

    North America

    ºÏ¹Ì
  • notifiable disease
    ½Å°í ´ë»ó º´
    Àü¿°¼º, ÁßÁõµµ ¹× ºóµµ ¶§¹®¿¡ Áß¾Ó, ÁÖ ¶Ç´Â Áö¹æ °üû¿¡ ¹ß»ý º¸°í¸¦ ¿äÇÏ´Â Áúȯ.
  • obliterative arterial disease
    Æó»ö¼º µ¿¸Æ Áúȯ
  • occupational disease
    Á÷¾÷º´
    1. ¾î¶² ƯÁ¤ Á÷¾÷¿¡ Á¾»çÇÔÀ¸·Î½á ±Ù·Î Á¶°ÇÀÌ ¿øÀÎÀÌ µÇ¾î ÀϾ´Â Áúȯ. ±× Á÷¾÷¿¡ Á¾»çÇϰí ÀÖÀ¸¸é ´©±¸µçÁö ÀÌȯµÉ °¡´É¼ºÀÌ ÀÖ´Â Á¡ÀÌ Æ¯»öÀ̸ç, ÀÛ¾÷ ȯ°æÀÇ ºÒºñ³ª ±Ù·Î °úÁßÀÌ °ãÃļ­ ¸¹Àº °æ¿ì¿¡ ¸¸¼ºÀÇ °æ°ú¸¦ °ÅÃÄ ¹ßº´ÇÑ´Ù. Á÷¾÷ ÀÚüÀÇ ¿øÀο¡ ÀÇÇÏ¿© ÀϾ´Â Áúº´¿¡´Â Á÷¾÷º´ ¿Ü¿¡, ÀçÇØ¼º ÁúȯÀÌ ÀÖ´Ù. ÀçÇØ¼º Áúȯµµ Á÷¾÷¿¡ Á¾»çÇϰí ÀÖ´Â ¸ðµç »ç¶÷¿¡°Ô ÀϾÁö¸¸, À¯µ¶ °¡½º³ª °í¿­¹°ÀÇ Æø¹ßÀÌ µ¹¹ßÀûÀ¸·Î ÀϾ´Â °Í°ú °°ÀÌ ¿ì¹ßÀûÀÎ »ç°íÀ̰ųª °ú½ÇÀ̹ǷΠÁ÷¾÷º´°ú´Â ±¸º°ÇÏ¿© »ý°¢Çϰí ÀÖ´Ù. Á÷¾÷º´Àº Á÷Àå Æ¯À¯ÀÇ º´À̱⠶§¹®¿¡ ¹ß»ý ¹æÁö¸¦ À§ÇÏ¿© ±× ¹ß»ý ¿øÀÎÀ» ±Ô¸íÇϰí, ȯ°æÀÇ °³¼± µî¿¡ ¿¹¹æ ´ëÃ¥À» ¼¼¿ìÁö ¾ÊÀ¸¸é ¾È µÈ´Ù. 2. Á÷¾÷¿¡ ¼ö¹ÝÇÏ´Â ÀÎÀÚ¿¡ ÀÇÇÑ Áúȯ, Áï ¿©·¯ °¡Áö ÇüÀÇ ÁøÆóÁõÀ̳ª ÇǺο° µîÀÌ ÀÖ´Ù.
  • Oguchi's disease
    ¿À±¸Ä¡ º´
    ÀϺ»¿¡¼­ ¹ß°ßÇÑ ¼±Ãµ¼º ¾ß¸ÍÁõÀÇ ÇÑ Çü.
  • Owren's disease
    ¿À¿ì·» º´
    ÀÀ°í ÀÎÀÚ VÀÇ °áÇÌ¿¡ ÀÇÇÑ µå¹® ÃâÇ÷¼º ¼ÒÀÎ, »ó¿°»öü ¿­¼º ¼ÒÁú·Î¼­ À¯ÀüµÈ´Ù.
  • Paas' disease
    ÆÄ½º º´
  • Paget's disease
    ÆÄ°Ù º´, ÆÄÁ¬ Áúȯ, ÆÄÁ¦Æ®º´, º¯Çü¼º °ñ¿°, ÆäÀÌÁ¬¾¾ º´
    1. Çϳª³ª ȤÀº ¿©·¯ °ñÀÇ ¿°ÁõÀ» µ¿¹ÝÇÏ´Â ¿øÀÎ ºÒ¸íÀÇ Àå¾Ö·Î¼­ ¹«Á¶Á÷¼º °ñ ȸº¹À» µ¿¹ÝÇÏ´Â °ñÀÇ ºñÈÄ¿Í ¿¬È­¸¦ ÀÏÀ¸Å²´Ù. 2. À¯¹æÀÇ Pagetº´Àº ¸¸¼º ½ÀÁø°ú À¯»çÇÏ°í ¾ÆÆ÷Å©¸°¼±ÀÌ ¸¹Àº ºÎÀ§¿¡ »ý±ä´Ù. Ç×¹® ÁÖÀ§¿¡ »ý±â´Â °Íº¸´Ù´Â ¿ÜÀ½ºÎ¿¡ »ý±â´Â °Í¿¡¼­ µ¿¹ÝµÈ ÇѼ± ¾ÏÀÌ ÀÖÀ» È®·üÀÌ ¸¹´Ù. À¯¹æÀÇ Pagetº´Àº ÀÏÃø¼º ¶Ç´Â µå¹°°Ô ¾çÃø¼ºÀ¸·Î ¿À´Â È«¹Ý¼º Àμ³¼º ÆÇÀ¸·Î Áø¹°ÀÌ ³¯ ¼ö ÀÖÀ¸¸ç ¶§¶§·Î À¯¹æ¾ÏÀÌ µ¿¹ÝµÈ´Ù. 3. °ñÀÇ ÀÌÇü¼º ÁúȯÀ¸·Î 40´ë ÈĹÝ, ³²¼º¿¡ ´õ ¸¹À¸³ª, ¿©¼º¿¡¼­ ´õ ½ÉÇÏ´Ù. ´Ù°ñ¼ºÀ¸·Î »êÀçÇÏ¿© Àå°ñ°ú ôÃß¿¡ ½ÉÇÑ º´º¯À» ¾ß±âÇÏ¿© º¯Çü°ú ºÒ±¸°¡ µÈ´Ù. µÎ°³°ñ°ú »ó¾Ç°ñÀÌ °úµµÇÏ°Ô ¼ºÀåÇϸç, ¶§·Î´Â ÇϾǰñÀÇ °úµµ ¼ºÀåµµ ÀϾ´Ù. 4. ÆÄ°ñ ¼¼Æ÷¿Í °ñ¸ð ¼¼Æ÷ Ȱ¼ºÀÌ Á¶È­¸¦ ÀÌ·çÁö ¸øÇϸ鼭 Å©±â´Â Ä¿ÁöÁö¸¸ ´õ ¾àÇÑ °ñÀ» ¸¸µå´Â ³ªÀÌµç ¼ºÀο¡¼­ ¹ß»ýÇÏ´Â ÁúȯÀ¸·Î µ¿ÅëÀÌ ±¤¹üÀ§ÇÏ°Ô ³ªÅ¸³ª¸ç, Ç÷û ¾ËÄ«¸®¼º Àλê È¿¼Ò¿Í ÇÏÀ̵å·Ï½Ã ÇÁ·Ñ¸°ÀÌ Áõ°¡µÇ°í ¾Ç¼º °ñ Á¾¾çÀ¸·Î ¹ßÀüÇÒ °¡´É¼ºÀÌ ³ô´Ù.
  • pandemic disease
    ¹üÀ¯Ç༺ º´
    ±¤¹üÀ§ÇÏ°Ô ÆÛÁ® ¹ß»ýÇÑ À¯Ç༺ Áúȯ.
  • Parkinsonian disease
    ÆÄŲ½¼¾¾ º´
    1. ¹«¿îµ¿Áõ, ÁøÀü, ±Ù °æÁ÷ÀÌ Æ¯Â¡ÀûÀÎ ½Å°æ Àå¾ÖÀÇ 1±º. 2. Á¤ÁöÇϰí ÀÖÀ» ¶§´Â ÁøÀüÀÌ ³ªÅ¸³ªÁö ¾Ê´Â ÁøÀü ¸¶ºñ.
  • pearl disease
    ÁøÁÖº´
    °¡ÃàÀÇ º¹¸· ¹× Àå°£¸· °áÇÙ.
  • pearl-worker's disease
    ÁøÁÖ°ø º´
    °ñ ºñ´ë¸¦ ¼ö¹ÝÇÏ´Â ¹Ýº¹¼º ¿°ÁõÀ¸·Î¼­, ÁøÁÖ ºÐ¸» ¶Ç´Â ¸ÕÁö°¡ ÀÖ´Â Àå¼Ò¿¡¼­ ÀÏÇÏ´Â »ç¶÷µé¿¡°Ô¼­ º¼ ¼ö ÀÖ´Ù.
  • Pellegrini's disease
    Æç·¹±×¸®´Ï º´
    ¹«¸­ÀÇ ³»º¹ÃøºÎ Àδë À§¿¡¼­ ¹Ý¿ù»ó °ñ Çü¼ºÀ» Ư¡À¸·Î ÇÏ´Â ÁúȯÀ¸·Î¼­ ¿Ü»ó¼º Àü½Å Àå¾Ö°¡ ¿øÀÎÀÌ´Ù.
  • pelvic inflammatory disease
    °ñ¹Ý¿° Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
altitude disease A condition that results from prolonged exposure to high altitude.
Symptoms include a continuous dry cough, shortness of breath, poor exercise tolerance, dizziness, headache, sleep difficulty, anorexia, confusion, fatigue and a rapid pulse.
Treatment includes the immediate movement to a lower altitude. Prophylaxis has been accomplished successfully with the use of acetazolamide (Diamox).
(27 Sep 1997)
alzheimer disease A degenerative organic mental disease characterised by progressive brain deterioration and dementia. The disease was originally described as dementia, presenile occurring in persons under the age of 65 (as opposed to dementia, senile with onset at or after 65); however, onset may occur at any age. There is no pathophysiological nor clinical distinction between the two stages of onset of alzheimer's. Women appear to be affected twice as frequently as men. It is characterised pathologically by the triad of senile plaques, neurofibrillary tangles, and neuropil threads.
(12 Dec 1998)
Alzheimer's disease <disease> A progressive, neurodegenerative disease characterised by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.
The cause of nerve cell death is unknown but the cells are recognised by the appearance of unusual helical protein filaments in the nerve cells (neurofibrillary tangles) and by degeneration in cortical regions of brain, especially frontal and temporal lobes.
Alzheimer's disease is the most common cause of dementia.
(22 May 1997)
anaemia of chronic disease <disease> A form of anaemia which develops as the result of a long-term infection or illness. Chronic diseases can interfere with red blood cell production in addition to shortening red blood cell life span in the body.
Symptoms are largely due to the underlying disease. Haemoglobin and haematocrit are generally low. Iron studies may be low to normal. Red blood cell indices may usually normal.
(27 Sep 1997)
anarthritic rheumatoid disease Rheumatoid disease without arthritis.
(05 Mar 2000)
Anders' disease <disease> A disease accompanied by painful localised fatty swellings and by various nerve lesions. It is usually seen in women and may cause death from pulmonary complications.
(12 Dec 1998)
Andersen's disease Familial cirrhosis of the liver with storage of abnormal glycogen; glycogenosis due to deficiency of 1,4-alpha-glucan branching enzyme, resulting in accumulation of abnormal glycogen with long inner and outer chains in liver, kidney, muscle, and other tissues.
Synonym: Andersen's disease.
(05 Mar 2000)
antibody deficiency disease <syndrome> Any of a group of disorders associated with a defective antibody production due to defects in the B-type lymphocyte system or in T-type lymphocytes; chief manifestation is an increased susceptibility to infection by various microorganisms.
See: agammaglobulinaemia, hypogammaglobulinaemia, immunodeficiency.
Synonym: antibody deficiency disease.
(05 Mar 2000)
anti-glomerular basement membrane disease Glomerulonephritis, usually of a generalised proliferative crescent-forming histologic type with a rapidly progressive course, marked by circulating anti-gbm antibodies and linear deposits of immunoglobulin and complement along the glomerular basement membrane. When associated with pulmonary haemorrhage the condition is called goodpasture syndrome.
(12 Dec 1998)
aortoiliac occlusive disease Obstruction of the abdominal aorta and its main branches by atherosclerosis.
(05 Mar 2000)
apical interstitial lung disease <radiology> A radiological diagnosis where fibrosis is seen in the apices (upper sections) of the lungs.
Likely causes include: cystic fibrosis, ankylosing spondylitis, sarcoidosis, silicosis, eosinophlic granuloma, TB and fungus, particularly aspergillus infection.
(25 Jun 1999)
Aran-Duchenne disease A serious neurologic disease that results from the progressive degeneration of the motor neurons.
(27 Sep 1997)
asbestos lung disease <radiology> Pleural plaques, earliest finding, may be only evidence, parietal pleura, 15-20 yrs after exposure, calcified after ca. 30 yrs, asbestosis, interstitial lung disease, perihilar regions to lung bases, shaggy heart, no cavitation or progressive massive fibrosis as in silicosis, crocidolite (blue) form most carcinogenic, associated with: malignant pleural mesothelioma, peritoneal mesothelioma, GI-tract malignancy
(12 Dec 1998)
asherman disease <radiology> Uterine synechiae, linear, lucent defects in uterus on HSG, usually secondary to endometrial trauma (D&C, etc.)
(12 Dec 1998)
atherosclerotic vascular disease <cardiology> The progressive narrowing and hardening of the arteries over time. This is known to occur to some degree with aging, but other risk factors that accelerate this process have been identified.
These factors include: high cholesterol, high blood pressure, smoking, diabetes and family history for atherosclerotic disease.
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 18
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 18
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 18
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 18
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 18
ÅëÇÕ°Ë»ö ¿Ï·á